Previous studies have found that the drugs that target a gene linked to the
disease are more likely to be approved. Yet there are many ways to define what
it means for a gene to be linked to the disease. Perhaps the most
straightforward approach is to rely on the genome-wide association studies (GWAS) data,
but that data can also be integrated with quantitative trait loci (eQTL or pQTL) information
to establish less obvious links between genetic variants (which often lie
outside of genes) and genes. Finally, there’s exome sequencing, which, unlike
GWAS, captures rare genetic variants. So in this paper, Marie and her
colleagues set out to benchmark these different methods against one another.
Listen to the episode to find out how these methods work, which ones
work better, and how network propagation can improve the prediction accuracy.
Podden och tillhörande omslagsbild på den här sidan tillhör
Roman Cheplyaka. Innehållet i podden är skapat av Roman Cheplyaka och inte av,
eller tillsammans med, Poddtoppen.
